{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:57:02Z","timestamp":1793051822429,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["[Postdoctoral GRANT PSTD23041794183]"],"award-info":[{"award-number":["[Postdoctoral GRANT PSTD23041794183]"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]},{"name":"South African Medical Research Association Council (SAMRC), the Centre of Excellence for Biomedical Tuberculosis Research"},{"name":"National Research Fund, South Africa","award":["Postdoctoral GRANT PSTD23041794183]"],"award-info":[{"award-number":["Postdoctoral GRANT PSTD23041794183]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91096-8","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:52:46Z","timestamp":1740707566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Repurposing of apoptotic inducer drugs against Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Kudakwashe","family":"Nyambo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivette","family":"Soko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudzanai Ian","family":"Tapfuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani","family":"Motaung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Adu-Amankwaah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Julius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwil","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Keyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Baatjies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liezel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kuben","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mkhuseli","family":"Ngxande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre G.","family":"Loxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuyo","family":"Mavumengwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"91096_CR1","unstructured":"Who. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. (2020)."},{"key":"91096_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1473-3099(21)00452-7","volume":"22","author":"A Penn-Nicholson","year":"2022","unstructured":"Penn-Nicholson, A. et al. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: A cross-sectional multicentre diagnostic accuracy study. Lancet Infect. Dis. 22, 242\u2013249 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"91096_CR3","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.014837-0","author":"F Ge","year":"2010","unstructured":"Ge, F. et al. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J Med. Microbiol. https:\/\/doi.org\/10.1099\/jmm.0.014837-0 (2010).","journal-title":"J Med. Microbiol."},{"key":"91096_CR4","doi-asserted-by":"publisher","first-page":"106591","DOI":"10.1016\/j.bioorg.2023.106591","volume":"138","author":"A Khalifa","year":"2023","unstructured":"Khalifa, A., Khalil, A., Abdel-Aziz, M. M., Albohy, A. & Mohamady, S. Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis. Bioorg. Chem. 138, 106591 (2023).","journal-title":"Bioorg. Chem."},{"key":"91096_CR5","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3390\/microorganisms10122334","volume":"10","author":"EG Salina","year":"2022","unstructured":"Salina, E. G. & Makarov, V. Mycobacterium tuberculosis dormancy: How to fight a hidden danger. Microorganisms 10, 2334 (2022).","journal-title":"Microorganisms"},{"key":"91096_CR6","doi-asserted-by":"publisher","first-page":"73230","DOI":"10.1371\/journal.pone.0073230","volume":"8","author":"SA Joosten","year":"2013","unstructured":"Joosten, S. A., Fletcher, H. A. & Ottenhoff, T. H. M. A helicopter perspective on TB biomarkers: Pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One 8, 73230 (2013).","journal-title":"PLoS One"},{"key":"91096_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00067","author":"J Estrella","year":"2011","unstructured":"Estrella, J. et al. A novel in vitro human macrophage model to study the persistence of mycobacterium tuberculosis using vitamin D3 and retinoic acid activated THP-1 macrophages. Front .Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2011.00067 (2011).","journal-title":"Front .Microbiol."},{"key":"91096_CR8","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.cimid.2019.101355","volume":"67","author":"A Madhvi","year":"2019","unstructured":"Madhvi, A., Mishra, H., Leisching, G. R., Mahlobo, P. Z. & Baker, B. Comparison of human monocyte derived macrophages and THP1-like macrophages as in vitro models for M. tuberculosis infection. Comp. Immunol. Microbiol. Infect. Dis. 67, 101355 (2019).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"91096_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00116","author":"Z Feng","year":"2020","unstructured":"Feng, Z. et al. Differential responses by human macrophages to infection with mycobacterium tuberculosis and non-tuberculous mycobacteria. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.00116 (2020).","journal-title":"Front. Microbiol."},{"key":"91096_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/icb.2008.97","volume":"87","author":"S Sharma","year":"2009","unstructured":"Sharma, S., Sharma, M. & Bose, M. Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells. Immunol. Cell Biol. 87, 226\u2013234 (2009).","journal-title":"Immunol. Cell Biol."},{"key":"91096_CR11","doi-asserted-by":"publisher","first-page":"0972","DOI":"10.1371\/journal.ppat.0030110","volume":"3","author":"K Velmurugan","year":"2007","unstructured":"Velmurugan, K. et al. Mycobacterium tuberculosis nuoG Is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog 3, 0972\u20130980 (2007).","journal-title":"PLoS Pathog"},{"key":"91096_CR12","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1111\/j.1742-4658.2010.07666.x","volume":"277","author":"LS Meena","year":"2010","unstructured":"Meena, L. S. & Rajni, T. Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J 277, 2416\u20132427 (2010).","journal-title":"FEBS J"},{"key":"91096_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4049\/jimmunol.170.1.430","volume":"170","author":"LM Sly","year":"2003","unstructured":"Sly, L. M., Hingley-Wilson, S. M., Reiner, N. E. & McMaster, W. R. Survival of Mycobacterium tuberculosis in Host Macrophages Involves Resistance to Apoptosis Dependent upon Induction of Antiapoptotic Bcl-2 Family Member Mcl-1. J. Immunol. 170, 430\u2013437 (2003).","journal-title":"J. Immunol."},{"key":"91096_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/iub.2002","volume":"71","author":"AH Ngwane","year":"2019","unstructured":"Ngwane, A. H. et al. The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug. IUBMB Life 71, 532\u2013538 (2019).","journal-title":"IUBMB Life"},{"key":"91096_CR15","doi-asserted-by":"publisher","first-page":"e1011387","DOI":"10.1371\/journal.ppat.1011387","volume":"19","author":"TL Cleverley","year":"2023","unstructured":"Cleverley, T. L. et al. The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas. PLoS Pathog. 19, e1011387 (2023).","journal-title":"PLoS Pathog."},{"issue":"1","key":"91096_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"J Xu","year":"2017","unstructured":"Xu, J. et al. A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity. Sci. Rep. 7(1), 1\u201310 (2017).","journal-title":"Sci. Rep."},{"key":"91096_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-323-91948-7.00016-6","volume-title":"Biology of Mycobacterial Lipids","author":"S Singh","year":"2022","unstructured":"Singh, S., Singh, D., Hameed, S. & Fatima, Z. An overview of mycolic acids: structure\u2013function\u2013classification, biosynthesis, and beyond. In Biology of Mycobacterial Lipids 1\u201325 (Elsevier, 2022). https:\/\/doi.org\/10.1016\/B978-0-323-91948-7.00016-6."},{"key":"91096_CR18","doi-asserted-by":"publisher","first-page":"19255","DOI":"10.1074\/jbc.M109.006940","volume":"284","author":"S Gavalda","year":"2009","unstructured":"Gavalda, S. et al. The Pks13\/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J. Biol. Chem. 284, 19255\u201319264 (2009).","journal-title":"J. Biol. Chem."},{"key":"91096_CR19","doi-asserted-by":"publisher","first-page":"10102","DOI":"10.3390\/ijms231710102","volume":"23","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Han, J., Zhu, Y., Tan, S. & Liu, H. Binding thermodynamics and dissociation kinetics analysis uncover the key structural motifs of phenoxyphenol derivatives as the direct inha inhibitors and the hotspot residues of InhA. Int. J. Mol. Sci. 23, 10102 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"91096_CR20","doi-asserted-by":"publisher","first-page":"e12406","DOI":"10.1016\/j.heliyon.2022.e12406","volume":"8","author":"KI Tapfuma","year":"2022","unstructured":"Tapfuma, K. I. et al. Antimycobacterial activity and molecular docking of methanolic extracts and compounds of marine fungi from Saldanha and False Bays. S. Afr. Heliyon 8, e12406 (2022).","journal-title":"S. Afr. Heliyon"},{"issue":"1","key":"91096_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-57124-9","volume":"14","author":"K Nyambo","year":"2024","unstructured":"Nyambo, K. et al. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Sci. Rep. 14(1), 1\u201322 (2024).","journal-title":"Sci. Rep."},{"key":"91096_CR22","unstructured":"Schr\u00f6dinger. LigPrep | Schr\u00f6dinger. Schr\u00f6dinger Release 2018\u20131 Preprint at (2021)."},{"key":"91096_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"91096_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/08927022.2021.2019251","author":"MA Ejalonibu","year":"2022","unstructured":"Ejalonibu, M. A., Elrashedy, A. A., Lawal, M. M., Mhlongo, N. N. & Kumalo, H. M. Pharmacophore mapping of the crucial mediators of dual inhibitor activity of PanK and PyrG in tuberculosis disease. Mol. Simul. https:\/\/doi.org\/10.1080\/08927022.2021.2019251 (2022).","journal-title":"Mol. Simul."},{"issue":"8","key":"91096_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41429-020-0331-4","volume":"73","author":"W Fenical","year":"2020","unstructured":"Fenical, W. Marine microbial natural products: the evolution of a new field of science. J. Antibiot. 73(8), 481\u2013487 (2020).","journal-title":"J. Antibiot."},{"key":"91096_CR26","doi-asserted-by":"publisher","first-page":"1056608","DOI":"10.3389\/fmicb.2022.1056608","volume":"13","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis. Front. Microbiol. 13, 1056608 (2022).","journal-title":"Front. Microbiol."},{"key":"91096_CR27","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.apsb.2022.04.014","volume":"12","author":"W Kuang","year":"2022","unstructured":"Kuang, W., Zhang, H., Wang, X. & Yang, P. Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis. Acta Pharm. Sin. B 12, 3201\u20133214 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"91096_CR28","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/molecules28031347","volume":"28","author":"LA Savintseva","year":"2023","unstructured":"Savintseva, L. A. et al. Conformational dynamics and stability of bilayers formed by mycolic acids from the mycobacterium tuberculosis outer membrane. Molecules 28, 1347 (2023).","journal-title":"Molecules"},{"key":"91096_CR29","doi-asserted-by":"publisher","first-page":"106434","DOI":"10.1016\/j.compbiomed.2022.106434","volume":"152","author":"N Phusi","year":"2023","unstructured":"Phusi, N. et al. Structure-based drug design of novel M. tuberculosis InhA inhibitors based on fragment molecular orbital calculations. Comput. Biol. Med. 152, 106434 (2023).","journal-title":"Comput. Biol. Med."},{"key":"91096_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008452","author":"J Zeng","year":"2020","unstructured":"Zeng, J. et al. Protein kinases PknA and PknB independently and coordinately regulate essential Mycobacterium tuberculosis physiologies and antimicrobial susceptibility. PLoS Pathog https:\/\/doi.org\/10.1371\/journal.ppat.1008452 (2020).","journal-title":"PLoS Pathog"},{"key":"91096_CR31","first-page":"529","volume":"10","author":"L Jordao","year":"2008","unstructured":"Jordao, L., Bleck, C. K. E., Mayorga, L., Griffiths, G. & Anes, E. On the killing of mycobacteria by macrophages. Cell Microbiol. 10, 529\u2013548 (2008).","journal-title":"Cell Microbiol."},{"key":"91096_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/microorganisms7050113","volume":"7","author":"S Sousa","year":"2019","unstructured":"Sousa, S., Borges, V., Joao, I., Gomes, J. P. & Jordao, L. Nontuberculous mycobacteria persistence in a cell model mimicking alveolar macrophages. Microorganisms 7, 113 (2019).","journal-title":"Microorganisms"},{"key":"91096_CR33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/ph15111318","volume":"15","author":"E Nuti","year":"2022","unstructured":"Nuti, E. et al. Identification of a novel p53 modulator endowed with antitumoural and antibacterial activity through a scaffold repurposing approach. Pharmaceuticals 15, 1318 (2022).","journal-title":"Pharmaceuticals"},{"key":"91096_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2013.03.022","volume":"153","author":"FJ Roca","year":"2013","unstructured":"Roca, F. J. & Ramakrishnan, L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 153, 521\u2013534 (2013).","journal-title":"Cell"},{"key":"91096_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.cell.2019.08.004","volume":"178","author":"FJ Roca","year":"2019","unstructured":"Roca, F. J., Whitworth, L. J., Redmond, S. & Jones, A. A. TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit. Cell 178, 1344-1361.e11 (2019).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91096-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91096-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91096-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:34:25Z","timestamp":1740749665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91096-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91096-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for this study was approved by the Research Ethics Committee: Biological and Environmental Safety (REC: BES) of Stellenbosch University with reference number BEE-2022\u20133188.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"7109"}}